Buy Femistra Tablet Online
About Femistra Tablet
Salt : Anastrozole (1mg)
Product Introduction
Femistra Tablet is used alone or with other treatments, such as surgery or radiation, to treat early breast cancer in postmenopausal women. It can also be used as the first line treatment of advanced breast cancer that has spread within the breast or to other areas of the body.
Femistra Tablet belong to a class of drug called aromatase inhibitors, which decreases the amount of estrogen in the body. It should be taken with or without food, but take it at the same time every day to get the most benefit. It should be taken as your doctor’s advice. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. Swallow the tablets whole with a drink of water. You should take this medicine for as long as it is prescribed for you.
The most common side effects of the medicine include hot flushes, nausea, rashes, joint pain, osteoporosis, and weakness. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them.
Before taking this medicine, tell your doctor if you are not gone through menopause and still having menstrual periods, or you have a problem with the liver or kidney. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. Tell your doctor if you are pregnant or breastfeeding. Your doctor may perform some blood tests to check for vitamin D level or bone density.
Uses of Femistra Tablet
- Breast cancer
Side effects of Femistra Tablet
Common side effects of Femistra
- Hot flashes
- Nausea
- Osteoporosis
- Skin rash
- Weakness
How to use Femistra Tablet
How Tablet works
Safety Advices
Pregnancy
Femistra Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast Feeding
Femistra Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby
Lungs
It is unknown if patients with lung conditions can consume Femistra 1mg tablet. So, before beginning the treatment, consult your doctor if you have any lung conditions.
Liver
Femistra Tablet should be used with caution in patients with liver disease. Dose adjustment of Femistra Tablet may be needed. Please consult your doctor.
Limited information is available on the use of Femistra Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Alcohol
It is not known whether it is safe to consume alcohol with Femistra Tablet. Please consult your doctor.
Driving
Femistra Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
What if you forget to take Femistra Tablet?
Quick tips
- Femistra Tablet is used for the treatment of hormone dependent breast cancer in postmenopausal women.
- Take it at the same time everyday.
- It may cause weakness and sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.
- Nausea may occur on starting treatment with this medicine but should go away with time. If nausea is bothersome, take it after meal.
- Your doctor may regularly check your Vitamin D level and bone mineral density and suggest supplements, if needed.
- Do not take Femistra Tablet if you are pregnant or breastfeeding.
Side Effects of Femistra 1mg Tablet
Side effects are unwanted symptoms produced by medication. Even though all medications cause side effects, not everyone gets them.
Serious
- Hypersensitive skin rash.
- Swelling of small blood vessels.
- Difficulty breathing and swallowing.
- Severe skin rash with blisters or ulcers, which is called Stevens-Johnson syndrome.
Common
- Loss of appetite
- Vaginal bleeding and dryness
- Bone loss (Osteoporosis)
- Inflammation of the joints (arthritis)
- Diarrhea, Nausea
- Depression
- Muscle pain
- Allergic hypersensitivity
- Bone pain
- Tingling, pain, coldness, weakness in parts of the hand.
- Hair thinning
Word of Advice
It is advised to inform your doctor if you have a history of osteoporosis and liver or kidney diseases. Femistra 1mg tablet reduces levels of the estrogen hormone. You can have weaker bones that are more likely to break. To maintain bone health in women who have gone through menopause, you should control these risks.
FAQs
Q 1. What is Tablet used for?
Femistra 1mg tablet is an anticancer drug. It belongs to the medication class known as aromatase inhibitors It is used to treat hormone-dependent breast cancer in postmenopausal women.
Q 2. Can children or adults takeTablet?
No, Femistra 1mg tablet is not recommended for children or adults. Talk with your doctor for more information.
Q 3. Can Tablet cause skin problems?
Yes, this medicine can cause skin problems such as skin rash, dry skin, and itching. This usually goes back to normal when your treatment finishes.
Q 4. Can tablet (Arimidex) cause bone disease?
Femistra 1mg tablet (Arimidex) can weaken your bones and increase your risk of fractures (a condition called osteoporosis). Your provider might ask you to do a bone mineral density (BMD) test while taking Femistra 1mg tablet (Arimidex) to ensure that your bones are healthy and strong.
Q 5. Can Tablet cause any kidney-related problems?
Care has to be given if you have any kidney-based problems. Inform your doctor if you have any history of kidney problems.
Q 6. I’m pregnant. Is that safe to take tablet?
No, It is unsafe to take Femistra 1mg tablet during pregnancy as it can cause harmful effects on the unborn baby.
Q 7. Can tablet cause any kidney-related problems?
Care has to be given if you have any kidney-based problems. Inform your doctor if you have any history of kidney problems.
Fact Box of Tablet
| Molecule name:Â Anastrozole | Therapeutic class:Â Anti-Cancer |
| Pharmacological class:Â Aromatase Inhibitor | Indication:Â Hormone-dependent breast cancer |
References
- Mylan, Electronic medicines compendium (EMC), [Revised on March 2021], [Accessed on Feb 16th, 2023], https://www.medicines.org.uk/emc/files/pil.2749.pdf
- Junmei Cairns; Anastrozole regulates fatty acid synthase in breast cancer; Published on Oct 2021; [Accessed on 16th Feb 2023];https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742770/
- ARIMIDEX, U.S Food & Drug Administration FDA, [Revised on Oct 2010] [ Accessed on Feb 16th, 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020541s026lbl.pdf
